Trinity Biotech PLC (NASDAQ:TRIB)

16.15
Delayed Data
As of May 22
 -0.05 / -0.31%
Today’s Change
14.00
Today|||52-Week Range
24.63
-7.77%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Trinity Biotech PLC have a median target of 26.50, with a high estimate of 30.00 and a low estimate of 21.00. The median estimate represents a +64.09% increase from the last price of 16.15.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Trinity Biotech PLC. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.14
Sales
$26.3M
Reporting Date
Jul 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -17.65%
 
 
 
 
 
 
Growthannually -5.40%
 
 
 
 
 
 

Sales

Growthquarterly 4.30%
 
 
 
 
 
 
Growthannually 5.51%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account